Video & Transcript Research : 'FDA'

Page 2 of 60
TX
TX

Texas 89th Regular

89th Legislative Session - Second Called Session Aug 28th, 2025

Texas House Floor Meeting

TX
TX

Texas 89th Regular

89th Legislative Session - Second Called Session Aug 28th, 2025

Texas House Floor Meeting

Transcript Highlights:
  • According to the FDA, from 2000 to June 2022, there were only 28 deaths out of 5.6 million women who
  • This bill strips away access to safe, proven, FDA-approved medications. that replaces medical judgment
  • medical freedom for a person of any age to buy a horse dewormer, ivermectin. ...Not approved by the FDA
  • care providers, even delivery companies and drivers that are providing women's... ...safe, affordable, FDA
  • , I'm going to say that one more again, FDA approved healthcare.
Bills: SB 8, HB7, HB15, HB 265, HCR 13, SB 8, HB 7, HB 15, HB 265, HCR 13
Keywords: sex designation, restroom access, civil penalties, private civil right of action, women's privacy, abortion, healthcare, jurisdiction, civil action, qui tam, prohibition, state law, youth camp, safety regulations, advisory committee, child welfare, health standards, summer camp, camp safety, child abuse reporting
LA
LA

Louisiana 2026 Regular Session

Health and Welfare May 6th, 2026

Health and Welfare

HI
HI

Hawaii 2026 Regular Session

House Chamber - Wed Apr 22, 2026, 12:00PM HST - Day 49

Hawaii House Floor Meeting

HI
HI

Hawaii 2026 Regular Session

RM 325 Conference PM - Wed Apr 22, 2026

Hawaii House Floor Meeting

HI
HI

Hawaii 2026 Regular Session

RM 309 Conference PM - Wed Apr 22, 2026

Hawaii House Floor Meeting

HI
HI

Hawaii 2026 Regular Session

RM 325 Conference PM - Wed Apr 22, 2026

Hawaii House Floor Meeting

OK
OK

Oklahoma 2026 Regular Session

Appropriations Revised Apr 22nd, 2026 at 03:30 pm

Appropriations

TX
TX

Texas 89th Regular

S/C on Disease Prevention & Women's & Children's Health Apr 17th, 2025

S/C on Disease Prevention & Women's & Children's Health

Transcript Highlights:
  • The FDA does not regulate what a physician... ...a physician can prescribe a medication for.
  • The FDA regulates—Chair recognizes Representative Cunningham as present.
  • The FDA regulates what the manufacturer of that drug can market it to providers for.
  • .. ...one that I was on previously changed and decided, "Well, we're just going to go with what the FDA
  • Now, of course, the FDA has ruled that you can't use certain private sources to get medications anymore
Bills: HB231, HB231, HB475, HB488, HB632, HB821, HB1786, HB1955, HB2036, HB2060, HB2659, HB2677
Keywords: HB 231, Texas Water Code, TCEQ, permit exemption, dam, reservoir, erosion control, flood control, floodwater control, sediment control, watershed protection, Natural Resources Conservation Service, NRCS, Watershed Protection and Flood Prevention Act, local sponsor, water appropriation, small dam, water diversion, maintenance, rehabilitation
TX
TX

Texas 89th Regular

S/C on Disease Prevention & Women's & Children's Health Apr 17th, 2025

S/C on Disease Prevention & Women's & Children's Health

OK
OK

Oklahoma 2026 Regular Session

Health and Human Services REVISED Mar 2nd, 2026 at 02:00 pm

Health and Human Services

Transcript Highlights:
  • What it does is it allows ivermectin to be sold over the counter with FDA approval.
  • Will this be with FDA approval?
  • I'm going to assume FDA will come down with the guidelines on how it should be done. Thank you, Mr.
  • So if FDA comes down with guidelines that require a prescription from a licensed prescriber, then will
Bills: SB1328, SB1380, SB1436, SB1558, SB1572, SB1651, SB1805, SB1831, SB1836, SB2014, SB2023, SB2044, SB2179, SB933
Keywords: parents' rights, healthcare consent, minors, medical records, protection, legal guardianship, hospital, fetal death, miscarriage, healthcare, state health department, vital records, patient rights, child care, licensing, definitions, foster care, child welfare, mental health, substance abuse
AZ
AZ

Arizona 2026 Regular Session

01/28/2026 - Senate Health and Human Services

Health and Human Services

Bills: SB1051, SB1114, SB1115, SB1122, SB1132, SB1162, SB1169, SB1171, SB1172, SB1173, SB1174, SB1175, SB1179, SB1188, SB1233, SB1236, SB1242, SB1316, SB1368
Keywords: SB1051, Arizona hospitals, immigration status, patient intake, admission forms, registration forms, health care reporting, uncompensated care, emergency department, lawfully present, undocumented immigrants, noncitizen patients, hospital funding, Arizona Department of Health Services, ADHS, border security, health care institutions, patient privacy, medical access, immigration policy
Summary: The Health and Human Services Committee approved the January 21 minutes and then heard a series of bills focused on developmental disabilities oversight, behavioral health fraud, AHCCCS operations, child safety, and state hospital capacity. SB 1179 would make the Developmental Disabilities Group Home Monitoring Program permanent and remove the appropriations contingency; Disability Rights Arizona and program managers testified that Commit had identified systemic care problems, while the sponsor said the work should continue. The bill received a 6-1 do-pass recommendation. SB 1114 would appropriate $1 million to the Maricopa County Attorney’s Office for behavioral health patient brokering investigations; Native advocates described widespread recruitment and exploitation of vulnerable people, especially Native Americans, and the bill passed 8-0. SB 1115 would prohibit AHCCCS from allowing remote work for Access employees; the sponsor argued in-person oversight was needed, while AHCCCS warned of space and staffing problems. It passed 4-3. SB 1051 would require hospitals to collect and report patients’ citizenship or immigration status for cost accounting; supporters called it a data-collection measure, while nurses and physicians said it would create fear and deter care. It passed 4-3. SB 1122, as amended, would replace prior authorization with 100% prepayment review for certain behavioral health services under the American Indian Health Plan, and passed 7-0 after AHCCCS said it had worked on the amendment. SB 1132, to appropriate unspecified funds for a new Arizona State Hospital wing, drew testimony from families and advocates describing severe shortages of state hospital beds and the need for more long-term treatment capacity; it passed 7-0. SB 1169, to fund graduate medical education and a new residency program, passed 6-0. SB 1171, requiring AHCCCS to check for dual enrollment in exchange plans and AHCCCS, passed 4-2-1 after AHCCCS said implementation would require system changes and costs. SB 1172, requiring more experienced DCS investigators for repeated abuse/neglect reports and court notification of hotline calls in dependency cases, passed 7-0. SB 1173, requiring behavioral health facility applicants, owners, and licensees to be U.S. citizens or lawfully present permanent residents with fingerprint clearance cards, passed 4-3 after an amendment clarifying the lawful-presence requirement.
TX
TX

Texas 89th Regular

Senate Committee on Health and Human Services Mar 18th, 2025

Health & Human Services

Transcript Highlights:
  • The original Right to Try gave patients the right to seek treatments that had passed the FDA safety trials
  • The FDA develops and approves more drugs than any other country in the world.
  • However, when previously approved treatments do not work for suffering patients, the FDA is simply too
  • The FDA, by its nature, amasses significant data.
  • It's unrealistic to expect the FDA to move as quickly as technology and advancements are.
Bills: SB95, SB268, SB493, SB619, SB660, SB922, SB984, SB1098, SB1188, SB1307, SB1332, SB1822
Keywords: immunization, written informed consent, civil liability, health care provider, vaccine compensation, administrative penalty, health care, licensing, complaint procedure, disciplinary action, law enforcement, pharmacy benefit manager, PBM, gag clause, prescription drug pricing, out-of-pocket cost, cash price, pharmacist, pharmacy, prescription drug benefit
TX
TX

Texas 89th Regular

Senate Committee on Health and Human Services (Part I) Mar 5th, 2025

Health & Human Services

Transcript Highlights:
  • This continuing theme of the FDA through Republican and Democratic. administrations just failing to do
  • And so the FDA has a list of 16 approved active ingredients for use in sunscreens.
  • A physician is determined that the standard FDA-approved products are less... effective, may recommend
  • I think this is about at the lowest what we to be doing to recognize what the FDA has done to us.
  • It's a good business sense to get the drugs out that were already FDA approved.
Bills: SB502, SB513, SB622, SB670, SB731, SB732, SB916, SB961, SB1122
Keywords: SB 502, Texas peace officers, Health and Human Services Commission, HHSC Office of Inspector General, OIG investigators, law enforcement classification, Schedule C, state employee benefits, injury benefits, peace officer status, commissioned officers, state auditor classification, Government Code, Code of Criminal Procedure, human services, health and human services, law enforcement compensation, public employee benefits, Texas state law enforcement, child welfare
TX
TX

Texas 89th Regular

Senate Committee on Health and Human Services (Part II) Mar 5th, 2025

Health & Human Services

TX
TX

Texas 89th Regular

Health and Human Services (Part II) Mar 5th, 2025

Health & Human Services

US
US

US Federal 2025-2026 Regular Session

Hearings to examine the nomination of Martin Makary, of Virginia, to be Commissioner of Food and Drugs, Department of Health and Human Services. Mar 6th, 2025 at 09:00 am

Health, Education, Labor, and Pensions Committee

Transcript Highlights:
  • That's the job there through the FDA.
  • Now the FDA concluded that Mifeprestone could not be safely used, I'm quoting the FDA there, safely used
  • We agreed that despite the need for reforms at the FDA, that the FDA is sort of the gold standard.
  • Now, that's not something. the FDA does, but the FDA can help provide data to help train machine learning
  • FDA does a tremendous service for our country.
Keywords: nominations, labor, health, veterans, Social Security, Elon Musk, transparency, government accountability
Summary: The meeting primarily focused on various executive nominations and their implications on labor and health affairs. Significant discussions surrounded the nomination of Mr. Sonderling as the Deputy Secretary of Labor, with members expressing concerns about workforce cuts affecting veterans and Social Security employees. There was also a debate led by a member regarding the authority and influence of private individuals, specifically citing Elon Musk's involvement in government decisions. Such discussions raised questions about transparency and accountability within governmental agencies, leading to a proposal for Mr. Musk to provide testimony before the committee.
AZ
AZ

Arizona 2026 Regular Session

02/18/2026 - House International Trade

International Trade

Transcript Highlights:
  • There's a medical reason they can't use the FDA-approved drug.
  • medical need that can't be met by an FDA-approved drug.
  • These standards are frequently reviewed with input from the FDA.
  • Chairman, Representative Austin, the FDA has discretion.
  • Again, as I said before, with the FDA, in this case, the FDA can maybe do some good, but we can't.
Bills: HB2746, HB2750, HB2765, HB4036
Keywords: trade offices, committee, Arizona commerce authority, stakeholder input, efficiency, Arizona-Sonora, Sonora, Mexico, trade commission, cross-border trade, bilateral trade, international trade, economic development, foreign relations, border economy, investment, infrastructure, business exchange, academic exchange, legislative commission
Summary: The committee first heard a presentation from Berthold Barak Karlich of Benor Capital on investment, innovation, and trade from a European perspective. He argued that legacy is about enabling future generations through open, connected systems rather than isolation, highlighted Austria’s “hidden champion” SMEs and strong education/research base, and said innovation thrives through international collaboration. He also discussed AI and deep tech investment, emphasizing photonic computing and the need to support hardware that enables future AI systems. In response to questions, he said Arizona appears friendly and strong in deep tech and that he will explore opportunities there. The committee then considered HB 2746, which creates a study committee on trade offices under the Arizona Commerce Authority to review existing trade offices, gather stakeholder input, and make recommendations. Members discussed oversight of Arizona’s trade offices in several countries and the need to evaluate effectiveness. The bill passed with a due pass recommendation by a 7-0 vote. HB 2750, which establishes the Arizona-Sonora Trade Commission to improve trade, commerce, and tourism ties with Sonora, Mexico, also passed, with some members expressing interest in further discussion about its relationship to the Arizona-Mexico Commission; it received a 5-1-1 recommendation. The committee next took up HB 4036, a bill regulating compounded GLP-1 weight-loss drugs and related bulk drug substances, including restrictions on sale and distribution, testing and sourcing requirements, advertising disclosures, penalties, and pharmacy board inspection authority. Supporters, including representatives from Novo Nordisk and the Partnership for Safe Medicines, argued the bill addresses unsafe imported ingredients, misleading advertising, and a surge in unregulated compounded weight-loss products. Opponents from the Arizona Pharmacy Association, a compounding pharmacist, and a physician said the bill would burden lawful compounders, raise costs, reduce access, and could affect other legitimate compounded medications. After extensive debate, the motion for a due pass recommendation failed on a 5-5 tie. Finally, the committee heard a strike-everything amendment to HB 2765 creating a vapor product manufacturer licensing framework, fees, penalties, and Department of Revenue oversight aimed at stopping smuggled vape products. The sponsor said the measure was intended to target illegal imports and protect children, while opponents from the Vapor Technology Association and Arizona Innovates argued it would burden lawful businesses and that the real problem is illegal actors and targeted enforcement. The discussion continued with questions about federal law, flavored vape products, and whether the bill would affect compliant manufacturers, but the transcript ends before any final vote on HB 2765.
AZ
AZ

Arizona 2026 Regular Session

01/06/2026 - Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies

Transcript Highlights:
  • , and some of these have even received breakthrough therapy designation by the FDA.
  • They're sponsored by drug developers who are seeking FDA approval.
  • FDA to treat 24.
  • approval. ...and reduce suffering now, not wait 20 years for FDA approval.
  • Support among lots of key people at HHS, VA, and FDA.
Keywords: 1182, all
Summary: The Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies met to discuss psychedelic-assisted treatments for serious mental health conditions, with a focus on psilocybin, ibogaine, MDMA, and related compounds. The chair framed the issue as a clinical and access problem for veterans, first responders, and others with PTSD, depression, TBI, addiction, and suicidal ideation, emphasizing that these therapies are intended for supervised medical settings rather than take-home use. Members reviewed research claims and policy trends, including FDA breakthrough therapy designations, state-level psychedelic legislation, and the role of Arizona’s right-to-try law in expanding access once federal approval is in place. Testimony came from Alan Mullen, a retired Army Special Forces veteran, who described his PTSD/TBI history and said ibogaine treatment helped him confront trauma and showed promise in reducing symptoms under strict medical monitoring. Dr. Sue Cisley of Scottsdale Research Institute described ongoing FDA-controlled trials in Arizona, said current medications often fail high-need patients, and urged removal of research barriers and preparation for right-to-try and expanded access. Dan Freiberg of the Professional Firefighters of Arizona said firefighters face chronic exposure to trauma, often rely on alcohol or other coping mechanisms, and need effective alternatives beyond traditional therapy. Dr. Chung Trin discussed late-stage psychedelic trials, the FDA breakthrough pathway, safety oversight, and the need for state readiness when approvals occur. Committee members asked about how the treatments work, whether they require psychotherapy support, safety concerns including suicidality and black-market abuse, patenting and synthetic versus natural versions, and costs compared with ketamine and other treatments. Witnesses said the therapies are administered with extensive screening, monitoring, and integration support, and argued that addiction potential appears low under medical supervision. The discussion ended with interest in sending correspondence to federal officials to support right-to-try cooperation and in continuing the research and policy work; no formal vote or action was taken in the portion provided.
US
US

US Federal 2025-2026 Regular Session

Hearings to examine biomedical research, focusing on keeping America's edge in innovation. Apr 30th, 2025 at 09:30 am

Senate Appropriations

Transcript Highlights:
  • For example, over the past 20 years, the FDA has approved more than 600 new cancer treatments, including
  • And while we're talking about government efficiency, let's not forget the FDA, which families trust to
  • Esham, the Executive Director from the Alliance for a Stronger FDA.
  • The FDA is doing clinical trials. So you've got a lot going that comes together.
  • Last year, I asked former FDA Commissioner Dr.